Research
February 22, 2022
UAMS Researchers Find COVID-19 Vaccine Hesitancy Prevalent Even Among Vaccinated
FAYETTEVILLE — Researchers with the University of Arkansas for Medical Sciences (UAMS) Office of Community Health and Research recently published four articles on a study they conducted that found that many adults in Arkansas receiving the COVID-19 vaccine are doing so despite experiencing some doubts about the shot. The researchers determined – through a survey…
February 15, 2022
UAMS Receives $10 Million to Expand Community-Based Outreach Efforts to Increase COVID-19 Vaccinations
LITTLE ROCK — The University of Arkansas for Medical Sciences (UAMS) has been awarded a $10 million grant from the U.S. Department of Health and Human Services (HHS) to fund COVID-19 outreach efforts across Arkansas. UAMS will use the grant to mobilize and deploy community health workers, patient navigators and social support specialists to the…
February 11, 2022
UAMS Part of New Statewide Core Facilities Exchange for Researchers
The Arkansas Research Alliance (ARA) on Tuesday launched the Core Facilities Exchange (CFE), which allows researchers across Arkansas to share resources and equipment. The CFE is a partnership with the six major research facilities in Arkansas, including the University of Arkansas for Medical Sciences (UAMS). The launch and demonstration of the web-based CFE platform included remarks…
January 26, 2022
UAMS’ Kevin D. Raney, Ph.D., Named Fellow of American Association for the Advancement of Science
LITTLE ROCK — Kevin D. Raney, Ph.D., a research leader at the University of Arkansas for Medical Sciences (UAMS), has been elected a Fellow of the American Association for the Advancement of Science (AAAS), the world’s largest general scientific society and publisher of the Science family of journals. Raney is professor and chair of the…
January 25, 2022
UAMS Research Team Finds COVID-19 Has Mutation Limits
LITTLE ROCK — A University of Arkansas for Medical Sciences (UAMS) research team has found that while the coronavirus can create dangerous variants like delta and omicron, its ability to mutate has limits that should help drug and vaccine makers trying to thwart it. Drawing from global databases with millions of sequenced SARS-CoV-2 genomes, the…
December 27, 2021
UAMS Stays on Course despite New Challenges from COVID-19 Pandemic
As UAMS did everything it could to fight COVID-19, it maintained its commitment to excellence and its core values during the public health crisis — a commitment that was noticed by multiple national organizations and publications.
December 7, 2021
UAMS Researchers Discover Potential Way to Control Immune Responses
LITTLE ROCK — Researchers at the University of Arkansas for Medical Sciences (UAMS) have discovered how a key switch in the body’s immune response is turned on and off, opening the door to new treatments for those with life-threatening, uncontrolled immune responses.
November 26, 2021
UAMS Testing ‘Big Advance’ in Spinal Cord Stimulation; First Arkansas Participant Now Pain Free
Cornelia Ann Smith’s severe chronic back pain disappeared almost as soon as the experimental spinal cord stimulator was activated in a procedure at the University of Arkansas for Medical Sciences (UAMS). “I realized the device was helping me immediately,” the Calico Rock, Ark., resident said. Then, back home, it really began to sink in. “I…
November 23, 2021
UAMS’ Analiz Rodriguez, M.D., Ph.D., Selected for Diversity in Clinical Trials Career Development Program
LITTLE ROCK — The Bristol Myers Squibb Foundation (BMSF), along with its partners National Medical Fellowships and the American Association for Cancer Research, selected University of Arkansas for Medical Sciences (UAMS) neurosurgeon Analiz Rodriguez, M.D., Ph.D., to participate in its Diversity in Clinical Trials Career Development Program.
November 22, 2021
UAMS Researchers Receive $1.5 Million to Study Impact of Maternal Diabetes on Fetal Neurodevelopment
LITTLE ROCK —Researchers at the University of Arkansas for Medical Sciences (UAMS) hope to gain important insights about fetal neurodevelopment in a new study with diabetic pregnant mothers. Funded by a four-year, $1.5 million grant from the National Institutes of Health (NIH), the first study of its kind will use advanced fetal monitoring techniques and…
Previous page Next page